Moreover, a study by Xin Zhang et al. in colitis-associated colorectal cancer showed that Treg-induced immune tolerance could be suppressed by inhibiting IDO expression and activation in tumor cells [145]. This evidence concerns the gene IDO1 and neoplasm.